Delta‐like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials. - Besse, Casandra E.; Winicki, Nolan M.; Puerta, Cristian; Hernandez, Moises; Yuan, Jason X.‐J.; Thistlethwaite, Patricia A. (Pulmonary Circulation, 2024)